✨ Medicines Classification
NEW ZEALAND GAZETTE, No. 153 — 18 DECEMBER 2014
Rupatadine
Ruxolitinib
Sapropterin
Selective androgen receptor modulators
Sildenafil and its structural analogues; except sildenafil in medicines for oral use containing 100 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 12 solid dosage units for the treatment of erectile dysfunction in males aged 35–70 years by a registered pharmacist who has successfully completed a training programme endorsed by the Pharmaceutical Society of New Zealand
Simeprevir
Sofosbuvir
Tafluprost
Taliglucerase alfa
Telaprevir
Terbinafine; except in medicines for dermal use
Teriflunomide
Tesamorelin
Ticagrelor
Tioconazole; except in medicines for vaginal or dermal use
Trametinib dimethyl sulfoxide
Tolvaptan
Trastuzumab emtansine
Trimethoprim; except in medicines for oral use containing 300 milligrams or less per dose unit when sold in a pack of 3 solid dosage units to a woman aged 16–65 years for the treatment of an uncomplicated urinary tract infection by a registered pharmacist who has successfully completed the New Zealand College of Pharmacists’ training in the treatment of urinary tract infections
Tuberculin
Umeclidinium bromide
Vandetanib
Varicella vaccine; except when administered for the prevention of herpes zoster (shingles) to a person 50 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health
Vedolizumab
Velaglucerase alfa
Vemurafenib
Vilanterol
Vismodegib
Vorinostat
Vortioxetine
Zoster immunoglobulin, human
Schedule 2
Restricted Medicines
Adrenaline; in medicines containing 1% or less except in medicines for injection containing 0.02% or less
Brompheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Chlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Ciclopirox; for external use in medicines containing more than 2%; in preparations for application to the nails
163
Next Page →
✨ LLM interpretation of page content
🏥
Classification of Medicines
(continued from previous page)
🏥 Health & Social WelfareMedicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines, Rupatadine, Ruxolitinib, Sapropterin, Selective androgen receptor modulators, Sildenafil, Simeprevir, Sofosbuvir, Tafluprost, Taliglucerase alfa, Telaprevir, Terbinafine, Teriflunomide, Tesamorelin, Ticagrelor, Tioconazole, Trametinib dimethyl sulfoxide, Tolvaptan, Trastuzumab emtansine, Trimethoprim, Tuberculin, Umeclidinium bromide, Vandetanib, Varicella vaccine, Vedolizumab, Velaglucerase alfa, Vemurafenib, Vilanterol, Vismodegib, Vorinostat, Vortioxetine, Zoster immunoglobulin, Adrenaline, Brompheniramine, Chlorpheniramine, Ciclopirox
NZ Gazette 2014, No 153